During the past decade, Clinical Hospital Centre Rijeka conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 18 clinical trials were completed, i.e. on average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Centre Rijeka" #1 sponsor was "University Hospital Rijeka" with 9 trials, followed by "Celgene" with 6 trials sponsored, "Pfizer" with 4 trials sponsored, "Takeda" with 4 trials sponsored and "Central European Cooperative Oncology Group" with 4 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Centre Rijeka" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Fresenius Medical Care North America" with 2 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "University of Rijeka" with 2 trials as a collaborator and "Belupo" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Centre Rijeka" are "Crohn Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Acute Pancreatitis" (2 trials) and "Chronic Kidney Disease Requiring Chronic Dialysis" (2 trials). Many other conditions were trialed in "Clinical Hospital Centre Rijeka" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Centre Rijeka" are "Drug" (34 trials), "Other" (8 trials), "Biological" (5 trials), "Dietary Supplement" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ozanimod" (3 trials), "Edoxaban" (2 trials), "PA21 (2.5 g tablet containing 500 mg iron)" (2 trials) and "RPC1063" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Centre Rijeka" are 48 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Hospital Centre Rijeka". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 31 completed trials in Clinical Hospital Centre Rijeka, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Centre Rijeka, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 4 trials that are defined as “Not Applicable".